Director, Operations (Southeast)
SymboticFull Time
Expert & Leadership (9+ years)
Candidates must possess a Bachelor's degree, with an advanced degree being preferred. A minimum of 10 years of biotech/pharma sales experience is required, including at least 3 years in a sales leadership role. Prior cross-functional experience and a proven track record in hematology/oncology and/or cell therapy markets are highly valued. Strong inspirational leadership, clear communication, and advanced coaching and team development skills are essential, as is an innovative and strategic mindset with experience in building, coaching, and implementing actionable account plans. The role requires at least 50% travel.
The Senior Division Manager will be responsible for attracting, retaining, and developing a high-performing divisional field sales team, onboarding and training them to exceed launch expectations, and leading them to meet and exceed sales and performance goals. This includes analyzing market trends and competitive activity to inform strategy, developing and implementing divisional sales plans aligned with company objectives, and supporting the team in executing strategic territory and account plans. The manager will also proactively engage with key customers to build relationships and advocacy, collaborate with partner organizations and key stakeholders, and lead commercial activities at scientific meetings, ensuring compliance with all regulatory and legal requirements.
Develops immunotherapies for cell therapy
Arcellx develops immunotherapies aimed at improving cell therapy for serious diseases. Their products focus on advanced techniques that enhance the effectiveness of treatments. The company collaborates with healthcare providers and research institutions to bring these therapies to patients. Unlike many competitors, Arcellx emphasizes proprietary products and partnerships to drive their research and development efforts. The goal is to meet unmet medical needs by providing safe and effective treatment options through their innovative approach to cell therapy.